Aurobindo gets USFDA nod for Cyclobenzaprine hydrochloride

Drug firm Aurobindo Pharma has received US Food and Drug Administration (USFDA) approval for marketing Cyclobenzaprine hydrochloride tablets, most widely prescribed as a muscle relaxant.     

The company has got the approval to market and distribute the drug in 10 mg and 5 mg strengths, according to the information available on the website of USFDA.     

Aurobindo Pharma is a Hyderabad-based pharmaceutical manufacturer.